These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7608433)

  • 1. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities.
    Marzullo P; Parodi O; Sambuceti G; Giorgetti A; Picano E; Gimelli A; Salvadori P; L'Abbate A
    J Am Coll Cardiol; 1995 Aug; 26(2):342-50. PubMed ID: 7608433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance.
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Ueda T; Temma S; Yonekura Y; Yamashita K; Konishi J; Mikawa H
    Am J Cardiol; 1991 Dec; 68(17):1638-45. PubMed ID: 1746466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS; deKemp R; Scheffel A; Nahmias C; Garnett ES; Coates G; Johansen HL; Fallen E
    J Am Coll Cardiol; 1997 Mar; 29(3):537-43. PubMed ID: 9060890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-function relation in patients with chronic coronary artery disease and reduced regional function. A positron emission tomographic and two-dimensional echocardiographic study with coronary vasodilator stress.
    Torres MA; Picano E; Parodi G; Sicari R; Veglia F; Giorgetti A; Marzullo P; Parodi O
    J Am Coll Cardiol; 1997 Jul; 30(1):65-70. PubMed ID: 9207622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography.
    Schwaiger M; Brunken R; Grover-McKay M; Krivokapich J; Child J; Tillisch JH; Phelps ME; Schelbert HR
    J Am Coll Cardiol; 1986 Oct; 8(4):800-8. PubMed ID: 3489746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.
    Vanoverschelde JL; Wijns W; Depré C; Essamri B; Heyndrickx GR; Borgers M; Bol A; Melin JA
    Circulation; 1993 May; 87(5):1513-23. PubMed ID: 8491006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease.
    Skopicki HA; Abraham SA; Weissman NJ; Mukerjee AK; Alpert NM; Fischman AJ; Picard MH; Gewirtz H
    Circulation; 1996 Aug; 94(4):643-50. PubMed ID: 8772683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
    Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
    J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Marin-Neto JA; Maurea S; Arrighi JA; Bonow RO
    J Am Coll Cardiol; 1994 Mar; 23(3):608-16. PubMed ID: 8113542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
    van den Heuvel AF; Bax JJ; Blanksma PK; Vaalburg W; Crijns HJ; van Veldhuisen DJ
    Cardiovasc Res; 2002 Jul; 55(1):97-103. PubMed ID: 12062712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium.
    Sawada S; Elsner G; Segar DS; O'Shaughnessy M; Khouri S; Foltz J; Bourdillon PD; Bates JR; Fineberg N; Ryan T; Hutchins GD; Feigenbaum H
    J Am Coll Cardiol; 1997 Jan; 29(1):55-61. PubMed ID: 8996295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Schicha H; Sechtem U
    J Am Coll Cardiol; 1994 Aug; 24(2):343-53. PubMed ID: 8034866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.
    Sun KT; Czernin J; Krivokapich J; Lau YK; Böttcher M; Maurer G; Phelps ME; Schelbert HR
    Circulation; 1996 Dec; 94(12):3146-54. PubMed ID: 8989122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.